| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | carbidopa, levodopa drug combination | FAERS: 149 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | teduglutide | FAERS: 6 | US FAERS | |
| 3 | lenvatinib | FAERS: 3 | US FAERS | |
| 4 | Capecitabine | FAERS: 1 | US FAERS | |
| 5 | Everolimus | FAERS: 1 | US FAERS | |
| 6 | Gabapentin | FAERS: 1 | US FAERS | |
| 7 | Octreotide | FAERS: 1 | US FAERS | |
| 8 | Paclitaxel | FAERS: 1 | US FAERS | |
| 9 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 10 | ambrisentan | FAERS: 1 | US FAERS | |
| 11 | Guaifenesin | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.